Disclosed positions

Estimated from their latest filings — positions may have changed since

$666.5K

combined est. value

Stock	Shares	Price	Value	Weight	As of
ABOSAcumen Pharmaceuticals, Inc.	255,371	$2.61	$666.5K	100%	2026-01-22

ABOS

Acumen Pharmaceuticals, Inc.

$666.5K

255,371 sh

All filings on record

Every Form 4 transaction we track for this filer

all 5buys 0sells 4

Stock	Transaction	Date	~6mo later
ABOSAcumen Pharmaceuticals, Inc.	Sell $1.6K · 895 sh	2026-01-22	—
ABOSAcumen Pharmaceuticals, Inc.	Sell $4.2K · 2,331 sh	2026-01-21	—
ABOSAcumen Pharmaceuticals, Inc.	Grant — · 99,133 sh	2026-01-16	—
ABOSAcumen Pharmaceuticals, Inc.	Sell $13.4K · 6,834 sh	2026-01-06	—
ABOSAcumen Pharmaceuticals, Inc.	Sell $7.8K · 4,000 sh	2026-01-05	—

ABOSSell

2026-01-22 · Acumen Pharmaceuticals, Inc.

$1.6K

—

ABOSSell

2026-01-21 · Acumen Pharmaceuticals, Inc.

$4.2K

—

ABOSGrant

2026-01-16 · Acumen Pharmaceuticals, Inc.

99,133

—

ABOSSell

2026-01-06 · Acumen Pharmaceuticals, Inc.

$13.4K

—

ABOSSell

2026-01-05 · Acumen Pharmaceuticals, Inc.

$7.8K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.